o
Yield: 0.38 g (97 %); M.P. = 222-224 C; IR (KBr): = 3073, 2961, 2877, 1668, 1630, 1604, 1510,
1469, 1360, 1313, 1270, 700 cm-1; H NMR (CDCl3, 400 MHz): δ = 1.23 (6H, s, 2CH3), 2.36 (2H, s,
CH2), 3.25 (1H, AB System, dd, JHH = 19.1 and JHH = 2.3 Hz, CH), 3.43 (1H, AB System, dd, JHH
19.1 and 4JHH = 1.2 Hz, CH), 6.45 (1H, s, CH), 7.03 (2H, t, 3JHH = 8.6 Hz, 2CH), 7.4-7.43 (2H, m, 2CH),
1
2
4
2
=
13
7.85-7.89 (2H, m, 2CH), 8.25-8.30 (1H, m, CH), 8.34-8.39 (1H, m, CH) ppm; C NMR (CDCl3, 100
MHz): δ = 28.4, 28.7, 37.9, 38, 50.8, 64.4, 115.6, 115.9, 118.2, 127.7, 128, 128.9, 129, 132.3, 133.6,
1
134.6, 151, 154.4, 156, 162.7 (d, JFC = 264 Hz), 192.2 ppm; Anal. Calcd for C23H19FN2O3 (390.4): C,
70.76; H, 4.91; N, 7.18; F, 4.87. Found: C, 70.81; H, 4.88; N, 7.28; F, 4.90 %.
3,4-Dihydro-3,3-dimethyl-13-(2-chlorophenyl)-2H-indazolo[2,1-b]phthalazine-1,6,11 (13H)-trione (4d
8b)
o
Yield: 0.36 g (88 %); M.P. = 262-264 C; IR (KBr): = 2958, 1666, 1469, 1360, 1314, 1270, 704 cm-1;
1H NMR (CDCl3, 400 MHz): δ = 1.22 (3H, s, CH3), 1.23 (3H, s, CH3), 2.34 (2H, s, CH2), 3.26 (1H, AB
System, dd, 2JHH = 19.1 and 4JHH = 2.3 Hz, CH), 3.42 (1H, AB System, dd, 2JHH = 19.1 and 4JHH = 1.1 Hz,
CH), 6.69 (1H, s, CH), 7.23-7.35 (3H, m, 3CH), 7.49-7.50 (1H, m, CH), 7.84-7.89 (2H, m, 2CH), 8.25-
8.28 (1H, m, CH), 8.37-8.39 (1H, m, CH) ppm; 13C NMR (CDCl3, 100 MHz): δ = 28.4, 28.8, 34.6, 38,
50.8, 64.1, 116.7, 127.7, 128, 128.7, 129.1, 129.9, 130.2, 130.5, 132.6, 133, 133.6, 134.5, 151.8, 154.2,
156.2, 192.1 ppm; Anal. Calcd for C23H19ClN2O3 (406.86): C, 67.89; H, 4.71; N, 6.89; Cl, 8.72. Found: C,
67.82; H, 4.76; N, 6.94; Cl, 8.68 %.
3,4-Dihydro-3,3-dimethyl-13-(4-bromophenyl)-2H-indazolo[2,1-b]phthalazine-1,6,11 (13H)-trione (4f,
8i)
o
1
Yield: 0.40 g (87 %); M.P. = 261-263 C; IR (KBr): = 2959, 1660, 1363, 1313, 1270, 697 cm-1; H
NMR (CDCl3, 400 MHz): δ = 1.22 (3H, s, CH3), 1.23 (3H, s, CH3), 2.36 (2H, s, CH2), 3.26 (1H, AB
System, dd, 2JHH = 19.1 and 4JHH = 2.3 Hz, CH), 3.42 (1H, AB System, dd, 2JHH = 19.1 and 4JHH = 1.2 Hz,
CH), 6.44 (1H, s, CH), 7.32 (2H, d, 3JHH = 8.6 Hz, 2CH), 7.38 (2H, d, 3JHH = 8.6 Hz, 2CH), 7.86-7.91(2H,
m, 2CH), 8.28-8.3 (1H, m, CH), 8.37-8.39 (1H, m, CH) ppm; 13C NMR (CDCl3, 100 MHz): δ = 28.5,
28.7, 34.7, 38.1, 50.9, 64.4, 118.1, 127.8, 128.1, 128.5, 128.9, 133.7, 134.5, 134.6, 134.9, 151.1, 154.4,
156, 192.1 ppm; Anal. Calcd for C23H19BrN2O3 (451.32): C, 61.21; H, 4.24; N, 6.21; Br, 17.71. Found: C,
61.28; H, 4.2; N, 6.18; Br, 17.65 %.
3,4-Dihydro-13-(2-chlorophenyl)-2H-indazolo[2,1-b]phthalazine-1,6,11(13H)-trione (4i, 8n)
o
Yield: 0.32 g (83 %); M.P. = 226-228 C; IR (KBr): = 3059, 2956, 2872, 1664, 1471, 1425, 1368,
1306, 1285, 1178, 703 cm-1; 1H NMR (CDCl3, 400 MHz): δ = 1.96-2.07 (1H, m, CH), 2.23-2.39 (1H, m,
CH), 2.46-2.49 (1H, m, CH), 2.52-2.67 (1H, m, CH), 3.35-3.42 (1H, m, CH), 3.51-3.57 (1H, m, CH), 6.69
(1H, s, CH), 7.06-7.52 (4H, m, 4CH), 7.86-7.88 (2H, m, 2CH), 8.26-8.28 (1H, m, CH), 8.37-8.39 (1H, m,
CH) ppm; 13C NMR (CDCl3, 100 MHz): δ = 22.3, 24.5, 36.9, 64.2, 117.7, 127.7, 128.1, 128.8, 129, 129.9,
130.2, 130.5, 132.7, 132.9, 133.3, 133.6, 134.5, 153.3, 154.2, 156.2, 192.4 ppm; Anal. Calcd for
C21H15ClN2O3 (378.81): C, 66.60; H, 3.99; N, 7.40; Cl, 9.36. Found: C, 66.65; H, 3.94; N, 7.44; Cl, 9.31
%.
17